- Approval Id
- bd00af1597db10d5
- Drug Name
- GALLIUM CITRATE (Ga 67) INJECTION 37 MBq/ml
- Product Name
- GALLIUM CITRATE (Ga 67) INJECTION 37 MBq/ml
- Approval Number
- SIN09913P
- Approval Date
- 1998-07-28
- Registrant
- QT INSTRUMENTS (S) PTE LTD
- Licence Holder
- QT INSTRUMENTS (S) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION
- Dosage
- **Dosage and administration**
Usual dose 74–111 MBq (2–3mCi) by intravenous injection.
- Route Of Administration
- INTRAVENOUS
- Indication Info
- **Indications**
Scintigraphy with gallium-67 is indicated in:
- the clinical evaluation of patients suspected of neoplastic diseases, notably Hodgkin’s disease, other malignant lymphomas, soft tissue sarcomas and most bronchogenic carcinomas.
- the localisation of metastases of malignant melanomas.
- the differentiation of hepatoma and liver metastases, and pleural and peritoneal mesotheliomas.
- determining the extent of involvement of malignancy.
- the follow-up of tumour therapy and screening for recurrent tumour.
- the localisation of focal inflammatory lesions and the evaluation of fever of unknown origin.
- Contraindications
- **Contraindications**
Gallium Citrate (Ga-67) Injection is contraindicated in lactating mothers unless the child is formula-fed for a period of at least three weeks after the injection.
No other contraindications are known.
- Atc Code
- V09HX01
- Atc Item Name
- gallium (67Ga) citrate
- Pharma Manufacturer Name
- QT INSTRUMENTS (S) PTE LTD
- Company Detail Path
- /organization/qt-instruments-s-pte-ltd
